Jacek Mackiewicz
16/18 Grunwaldzka Street
Poznan, WP 60786, Poland
Poznan, WP 60786, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2025
Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy.
Journal: International journal of molecular sciences
Published: June 12, 2025
Harnessing the synergy of contact brachytherapy and immune checkpoint inhibitors in advanced melanoma: first reported case series.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: May 07, 2025
Chemotherapy efficacy in advanced melanoma patients after failure of immune checkpoint and BRAF/MEK inhibitors.
Journal: Contemporary oncology (Poznan, Poland)
Published: February 04, 2025
lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients.
Journal: Biomedicines
Published: January 17, 2025
Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence.
Journal: Contemporary oncology (Poznan, Poland)
Published: December 19, 2024
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow-up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 06, 2024
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients.
Journal: International journal of molecular sciences
Published: October 24, 2024
Pair-matched analysis of Circulating Melanoma Cells (CMCs) before and after Immunotherapy in Relation to other Melanoma-Specific Biomarkers.
Journal: Journal of Cancer
Published: August 09, 2024
Recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society and Immuno-oncology Section of Polish Society of Oncology on oncological risk in patients with multiple sclerosis undergoing immunomodulatory therapy.
Journal: Neurologia i neurochirurgia polska
Published: August 09, 2024
Last Updated: 09/26/2026